|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1301 to 1357 out of 1357 for Egr2

<< First    < Previous  |  Next >    Last >>
0.026s
Type Details Score
Genotype
Symbol: Egr2/Egr2
Background: B6.Cg-Egr2
Zygosity: hm
Has Mutant Allele: true
DO Term
GXD Expression
Probe: MGI:5436064
Assay Type: RNA in situ
Annotation Date: 2012-09-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3282012
Pattern: Regionally restricted
Stage: TS12
Assay Id: MGI:5436256
Age: embryonic day 8.0
Image: 1H
Note: The stripes of expression in prospective rhombomeres 3 and 5 broadened and formed sharp boundaries. The domains coincided with Egr2 (Krox-20 lacZ staining). Expression was downregulated in rhombomere 4, but persisted at low level in 2 and dorsally in 6.
Specimen Label: 1H
Detected: true
Specimen Num: 9
GXD Expression
Probe: MGI:17719
Assay Type: RNA in situ
Annotation Date: 1999-05-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1608911
Pattern: Regionally restricted
Stage: TS11
Assay Id: MGI:1335751
Age: embryonic day 7.75
Image: 2.B
Note: A broad domain of expression is seen in the hindbrain. Higher levels of expression are coincident with the domain of Egr2 (Krox20) expression; lower levels extend to a boundary in the posterior hindbrain.
Specimen Label: 2.B
Detected: true
Specimen Num: 2
Allele
Name: regulatory region 102; targeted mutation 1.1, Mouse Clinical Institute
Allele Type: Targeted
Attribute String: Conditional ready, Modified regulatory region
Allele
Name: regulatory region 102; targeted mutation 1.2, Mouse Clinical Institute
Allele Type: Targeted
Attribute String: Modified regulatory region
Protein Domain
Type: Domain
Description: Wilm's tumour (WT) is an embryonal malignancy of the kidney, affecting around 1 in 10,000 infants. It occurs in both sporadic and hereditary forms. Inactivation of WT1 is one of the causes of Wilm's tumour. Defects in the WT1 gene are also associated with Denys-Drash Syndrome (DDS), which is characterised by typical nephropathy and genital abnormalities. The WT1 gene product shows similarity to the zinc fingers of the mammalian growth regulated EGR1 and EGR2 proteins [, , , ].
Publication
First Author: Belin S
Year: 2019
Journal: Hum Mol Genet
Title: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.
Volume: 28
Issue: 8
Pages: 1260-1273
Genotype
Symbol: Rr102/Rr102
Background: involves: C57BL/6 * DBA/2
Zygosity: hm
Has Mutant Allele: true
Protein Domain
Type: Family
Description: Wilm's tumour (WT) is an embryonal malignancy of the kidney, affecting around 1 in 10,000 infants. It occurs in both sporadic and hereditary forms. Inactivation of WT1 is one of the causes of Wilm's tumour. Defects in the WT1 gene are also associated with Denys-Drash Syndrome (DDS), which is characterised by typical nephropathy and genital abnormalities. The WT1 gene product shows similarity to the zinc fingers of the mammalian growth regulated EGR1 and EGR2 proteins [, , , ].This entry represents a Wilm's tumour protein.
Allele
Name: transgene insertion D, John Svaren
Allele Type: Transgenic
Attribute String: Reporter
Allele
Name: transgene insertion, John Svaren
Allele Type: Transgenic
Attribute String: Reporter
Allele
Name: transgene insertion E, John Svaren
Allele Type: Transgenic
Attribute String: Reporter
Publication
First Author: Buckler AJ
Year: 1991
Journal: Mol Cell Biol
Title: Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.
Volume: 11
Issue: 3
Pages: 1707-12
Publication
First Author: Rauscher FJ 3rd
Year: 1993
Journal: FASEB J
Title: The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
Volume: 7
Issue: 10
Pages: 896-903
Publication
First Author: Gessler M
Year: 1990
Journal: Nature
Title: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
Volume: 343
Issue: 6260
Pages: 774-8
Publication
First Author: Little MH
Year: 1992
Journal: Proc Natl Acad Sci U S A
Title: Zinc finger point mutations within the WT1 gene in Wilms tumor patients.
Volume: 89
Issue: 11
Pages: 4791-5
Publication
First Author: Jiang Y
Year: 2014
Journal: Cancer Discov
Title: Tracing the roots of cancer evolution.
Volume: 4
Issue: 9
Pages: 995-7
Genotype
Symbol: Rr102/Rr102<+> Rr111/Rr111<+>
Background: involves: C57BL/6 * DBA/2
Zygosity: cx
Has Mutant Allele: true
Publication
First Author: Rengarajan J
Year: 2000
Journal: Immunity
Title: Sequential involvement of NFAT and Egr transcription factors in FasL regulation.
Volume: 12
Issue: 3
Pages: 293-300
Publication
First Author: Patwardhan S
Year: 1991
Journal: Oncogene
Title: EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors.
Volume: 6
Issue: 6
Pages: 917-28
Publication
First Author: He Y
Year: 2010
Journal: Nat Neurosci
Title: Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination.
Volume: 13
Issue: 12
Pages: 1472-80
HT Experiment
Series Id: GSE14242
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: ArrayExpress
Publication
First Author: Tourtellotte WG
Year: 1998
Journal: Nat Genet
Title: Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3.
Volume: 20
Issue: 1
Pages: 87-91
Publication
First Author: Bedel R
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity.
Volume: 111
Issue: 1
Pages: E119-28
Publication
First Author: Liu S
Year: 2009
Journal: Mol Endocrinol
Title: Novel regulators of Fgf23 expression and mineralization in Hyp bone.
Volume: 23
Issue: 9
Pages: 1505-18
Publication
First Author: Hong J
Year: 2024
Journal: Glia
Title: PMP2 regulates myelin thickening and ATP production during remyelination.
Volume: 72
Issue: 5
Pages: 885-898
Publication
First Author: Märklin M
Year: 2017
Journal: Nat Commun
Title: NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.
Volume: 8
Issue: 1
Pages: 755
Publication  
First Author: Li C
Year: 2011
Journal: Neuroscience
Title: Microarray analysis of gene expression changes in the brains of NR2B-induced memory-enhanced mice.
Volume: 197
Pages: 121-31
Publication
First Author: Tourtellotte WG
Year: 2000
Journal: Mol Cell Biol
Title: Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis.
Volume: 20
Issue: 14
Pages: 5261-8
Publication
First Author: Hu Q
Year: 2022
Journal: Diabetes
Title: Obesity-Induced miR-455 Upregulation Promotes Adaptive Pancreatic β-Cell Proliferation Through the CPEB1/CDKN1B Pathway.
Volume: 71
Issue: 3
Pages: 394-411
Publication  
First Author: Hastings KT
Year: 2017
Journal: Mol Immunol
Title: Nab2 maintains thymus cellularity with aging and stress.
Volume: 85
Pages: 185-195
Publication
First Author: Hung H
Year: 2012
Journal: J Neurosci
Title: The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.
Volume: 32
Issue: 5
Pages: 1517-27
Publication
First Author: Tang Y
Year: 2015
Journal: Cardiovasc Res
Title: MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.
Volume: 106
Issue: 3
Pages: 387-97
Publication  
First Author: Torres OV
Year: 2015
Journal: Sci Rep
Title: CAMKII-conditional deletion of histone deacetylase 2 potentiates acute methamphetamine-induced expression of immediate early genes in the mouse nucleus accumbens.
Volume: 5
Pages: 13396
Publication
First Author: Ryu EJ
Year: 2007
Journal: J Neurosci
Title: Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss.
Volume: 27
Issue: 43
Pages: 11552-9
Publication  
First Author: Benturquia N
Year: 2008
Journal: Brain Res
Title: Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.
Volume: 1211
Pages: 1-5
Publication
First Author: Shieh JT
Year: 2011
Journal: PLoS One
Title: Elevated miR-499 levels blunt the cardiac stress response.
Volume: 6
Issue: 5
Pages: e19481
Publication
First Author: Salotti J
Year: 2015
Journal: Mol Cell Biol
Title: An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.
Volume: 35
Issue: 5
Pages: 866-83
Publication
First Author: Sun JJ
Year: 2017
Journal: Sci Rep
Title: Embryonic hindbrain patterning genes delineate distinct cardio-respiratory and metabolic homeostatic populations in the adult.
Volume: 7
Issue: 1
Pages: 9117
Publication
First Author: Zhang X
Year: 2020
Journal: Cell Mol Immunol
Title: TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK/ERK signaling pathway.
Volume: 17
Issue: 4
Pages: 395-406
Protein
Organism: Mus musculus/domesticus
Length: 449  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 305  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 288  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 406  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 360  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 517  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 302  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 406  
Fragment?: true
Publication  
First Author: Calella AM
Year: 2007
Journal: Neural Dev
Title: Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription.
Volume: 2
Pages: 4
Publication  
First Author: Desouza LA
Year: 2021
Journal: Front Mol Neurosci
Title: The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex.
Volume: 14
Pages: 790213
Publication
First Author: Mu C
Year: 2017
Journal: J Leukoc Biol
Title: Enhanced suppression of polyclonal CD8+25+ regulatory T cells via exosomal arming of antigen-specific peptide/MHC complexes.
Volume: 101
Issue: 5
Pages: 1221-1231
Publication
First Author: Rondahl V
Year: 2013
Journal: PLoS One
Title: Lrig2-deficient mice are protected against PDGFB-induced glioma.
Volume: 8
Issue: 9
Pages: e73635
Publication  
First Author: Fujikawa Y
Year: 2024
Journal: Front Immunol
Title: Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.
Volume: 15
Pages: 1168323
Publication      
First Author: European Mouse Mutant Archive
Year: 2003
Journal: Unpublished
Title: Information obtained from the European Mouse Mutant Archive (EMMA)
Publication
First Author: Gerhard DS
Year: 2004
Journal: Genome Res
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Volume: 14
Issue: 10B
Pages: 2121-7
Publication
First Author: Church DM
Year: 2009
Journal: PLoS Biol
Title: Lineage-specific biology revealed by a finished genome assembly of the mouse.
Volume: 7
Issue: 5
Pages: e1000112